Follicular flushing leads to higher oocyte yield in monofollicular IVF: a randomized controlled trial.

Kohl Schwartz, A. S.; Calzaferri, I; Roumet, M.; Limacher, A.; Fink, A.; Wueest, A; Weidlinger, S.; Mitter, V.R.; Leeners, B; Von Wolff, M. (2020). Follicular flushing leads to higher oocyte yield in monofollicular IVF: a randomized controlled trial. Human reproduction, 35(10), pp. 2253-2261. Oxford University Press 10.1093/humrep/deaa165

Preview

Text KohlSchwartz HumReprod 2020.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (275kB) | Preview

STUDY QUESTION

Does follicular flushing increase the number of mature oocytes in monofollicular IVF?

SUMMARY ANSWER

Follicular flushing increases the number of mature oocytes in monofollicular IVF.

WHAT IS KNOWN ALREADY

Flushing increases neither the oocyte yield nor the pregnancy rate in polyfollicular IVF or in poor responder patients. In monofollicular IVF, the effect of flushing has so far been addressed by two studies: (i) a prospective study with minimal stimulation IVF demonstrated an increased oocyte yield, and (ii) a retrospective study with natural cycle (NC)-IVF showed an increased oocyte yield and an increased transfer rate.

STUDY DESIGN, SIZE, DURATION

Randomized controlled trial including 164 women who were randomized for either aspiration with or without flushing from 2016 to 2019.

PARTICIPANTS/MATERIALS, SETTING, METHODS

Infertile women 18-42 years of age with an indication for IVF treatment at a university-based infertility unit. Women undergoing monofollicular IVF were randomized to either follicular aspiration only or follicular aspiration directly followed by five follicular flushes at a 1:1 ratio. The intervention was done without anaesthesia, using a gauge 19 single-lumen needle. Flushing volume was calculated (sphere formula) based on the size of the follicle.

MAIN RESULTS AND THE ROLE OF CHANCE

A total of 164 women were included; 81 were allocated to 'aspiration only' and 83 to additional 'flushing'. Primary analysis was based on the intention-to-treat: oocyte yield, defined as the collected mature oocyte rate, was higher (n = 64/83, 77.1%) in the flushing group compared to the aspiration only group (n = 48/81, 59.3%, adjusted risk difference (RD): 18.2% (95% CI 3.9-31.7%), P-value = 0.02). In the flushing group, most oocytes were retrieved within the first three flushes (63/83, 75.8%). Fertilization rate was higher in the flushing group (n = 53/83, 63.9% vs n = 38/81, 46.9%; adjusted RD: 16.8% (96% CI 1.5-31.4%), P = 0.045). Transfer rate was also higher in the flushing group (n = 52/83, 62.7% vs n = 38/81, 46.9%; RD: 15.71 (95% CI 0.3-30.3%)), but the difference was not significant (P = 0.06). The clinical pregnancy rate n = 9/83 versus n = 9/81 (RD: -0.3% (95% CI -9.9% to 9.5%)) and live birth rate n = 7/83 versus n = 8/81 (RD: -1.5% (95% CI -10.4% to 7.1%)) were not significantly different between the flushing and the aspiration group. The median duration of the intervention was significantly longer with flushing (2.38 min; quartiles 2.0, 2.7) versus aspiration only (0.43 min; quartiles 0.3, 0.5) (P < 0.01). There was no significant difference in the mean (±SD) visual analogue scales pain score between the follicular flushing (3.4 ± 1.8) and the aspiration group (3.1 ± 1.89).

LIMITATIONS, REASONS FOR CAUTION

Blinding of the procedure was not possible.

WIDER IMPLICATIONS OF THE FINDINGS

Our study proved that flushing of single follicles in NC-IVF increases the oocyte yield. In contrast to polyfollicular IVF flushing seems to be beneficial in a monofollicular setting if the technique used in our study (single-lumen needle, 5 flushings with flushing volume adaptation) is applied.

STUDY FUNDING/COMPETING INTEREST(S)

The study was funded by the financial sources of the division and in part by a research grant provided by NMS Biomedical SA, Switzerland. The company did not have any roles in design or conduct of the study or in the preparation of the manuscript. The authors have no other conflicts of interest.

TRIAL REGISTRATION NUMBER

Clinicaltrials.gov NCT02641808.

TRIAL REGISTRATION DATE

29 December 2015.

DATE OF FIRST PATIENT’S ENROLMENT

22 August 2016.

Interest & Impact

Downloads

96 since deposited on 01 Sep 2020
9 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item